Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Mirum Pharmaceuticals is a US-based biopharmaceutical company specializing in the development of innovative therapies for rare liver diseases. Through cutting-edge research, the company addresses critical unmet medical needs for pediatric patients around the world.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Mirum Pharmaceuticals is scheduled to report its next quarterly earnings on 11/17/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Mirum Pharmaceuticals last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -1.06 USD.
Across its last 3 earnings reports, Mirum Pharmaceuticals stock moved by ±10.9% on average the following day. The largest reaction was -15.1% on 02/25/2026; 0 of 3 reactions were positive.
Mirum Pharmaceuticals has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.